The UK High Court dismisses interim injunction in abuse of dominance case concerning refusal to supply in HIV prescription medicines market (Chemistree Homecare / Abbvie)

On 11 February 2013, the English High Court dismissed an application for an interim injunction in an abuse of dominance case concerning an alleged refusal to supply a patented HIV prescription medicine. Chemistree Homecare Ltd (the “claimant”) had applied for an interim injunction against Abbvie Ltd (the “defendant”) concerning supplies of a patented medical product marketed under the brand name Kaletra®, a protease inhibitor used in combination therapies of antiretroviral (“ARV”) medicines for HIV patients. The claimant is a pharmacy business, primarily involved in the supply of homecare services to NHS hospitals but also in dispensing medicines and delivering them to patients’ homes and administering them to patients. It is also active as a medical wholesaler. The defendant supplies and

L'accès à cet article est réservé aux abonnés

Déjà abonné ? Identifiez-vous

L’accès à cet article est réservé aux abonnés.

Lire gratuitement un article

Vous pouvez lire cet article gratuitement en vous inscrivant.

 

Version PDF

Auteur

  • Van Bael & Bellis (Brussels)

Citation

Tim Kasten, The UK High Court dismisses interim injunction in abuse of dominance case concerning refusal to supply in HIV prescription medicines market (Chemistree Homecare / Abbvie), 11 février 2013, e-Competitions February 2013, Art. N° 57222

Visites 254

Tous les numéros

  • Latest News issue 
  • Tous les News issues
  • Latest Special issue 
  • Tous les Special issues